Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
Clinical trial NCT06153693 · COMPLETED
Trial details
- NCT number
- NCT06153693
- Sponsor
- Mineralys Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-22
- Primary completion
- 2024-12-10
- Enrollment
- 1083
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.